For Ismail Harerimana, the 1990s in Uganda were defined by a relentless cycle of illness. As a child, he suffered from recurring bouts of malaria, persistent skin rashes, and chronic exhaustion. By age 14, he had become alarmingly thin, leading his father to claim he was being treated for a kidney condition. The truth only surfaced during a conversation with a classmate who shared the same medication regimen. When Harerimana asked if his friend was also being treated for kidney issues, the boy replied simply: “No — I’m suffering from AIDS.”
Today, the medical community maintains that an HIV-free generation is a reachable goal. Science has provided the tools to ensure that no baby is born with the virus, yet progress has stalled. Approximately 120,000 children are newly infected with HIV each year, typically during pregnancy, childbirth, or breastfeeding, according to UNAIDS data. As global funding for HIV prevention faces significant volatility, the promise of eradicating pediatric HIV is being overshadowed by a shift in foreign assistance priorities that threatens to undo decades of hard-won progress.
From Crisis to Control: The Evolution of Care
The landscape of pediatric HIV has changed radically since the 1990s. During the height of the crisis in Uganda, as many as one in four infants in some regions were born with HIV, and roughly half of those children did not survive until their second birthday. The introduction of antiretroviral therapies (ARVs) fundamentally altered this trajectory. When administered to expectant parents, these treatments make the virus virtually untransmittable. In success stories like Botswana, the progress has been so profound that the nation was certified by the World Health Organization as the first country with a high HIV burden to effectively eliminate mother-to-child transmission as a public health threat.
Despite these successes, the “last mile” of prevention remains elusive. Doris Macharia, president of the Elizabeth Glaser Pediatric AIDS Foundation, emphasizes that the challenge is no longer purely scientific. “We are actually confronting what it will take to finish this job,” Macharia said. “That is profound. That is progress. And that’s where we should be.” The barrier, she notes, is one of delivery and systems, particularly in reaching rural populations and parents who lack consistent access to prenatal care.
The Impact of Funding Shifts
The global response to pediatric HIV has been heavily bolstered by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), which launched in 2003. Since its inception, the program has been credited with preventing millions of infant infections. However, the current transition toward bilateral agreements—which require recipient countries to assume a larger share of the financial burden—has created a period of instability. Outreach programs, which are essential for identifying HIV-positive pregnant individuals who are not yet in the clinical system, are experiencing reduced capacity.
Organizations like Mothers2Mothers, which trains peer mentors to guide HIV-positive mothers through treatment, have faced significant funding disruptions. In Lesotho, for example, the reduction in available resources has forced a contraction of services, leaving fewer mentors to support a high volume of patients. Mpolokeng Mohloai, director of the group in Lesotho, noted that while the goal of government ownership is valid, the current systems are not yet prepared to absorb the full scope of these essential community-based services.
The potential consequences are stark. Projections by UNAIDS suggest that if sustained aid cuts continue, the world could see up to 1.1 million additional HIV infections in children and 820,000 more deaths between 2024 and 2040. For Harerimana, who now works as a community health worker, these statistics are not abstract. He reports seeing an increase in babies born with HIV in his local community—a trend he describes as a return to the fear and uncertainty of the 1990s.
The Road Ahead
While the transition in aid delivery is ongoing, the immediate reality for many families is a struggle to maintain access to life-saving medication. The shift toward country-led funding models is intended to ensure long-term sustainability, but advocates argue that the pace of this transition is outpacing the readiness of national health infrastructures. Without a phased, well-supported approach, the gains made in reducing mother-to-child transmission risk being eroded.
The next major checkpoint for global HIV stakeholders will be the upcoming international health summits where nations are expected to report on their progress toward the 2030 Sustainable Development Goals regarding communicable diseases. These meetings will provide a clearer picture of how effectively bilateral agreements are bridging the gaps left by the restructuring of international aid programs. As the global community evaluates these shifts, the focus remains on the “last mile”—ensuring that every expectant parent, regardless of geography, has the resources to prevent the transmission of HIV to their child.
This article provides informational context on global health policy and is not intended as medical advice. For more information on HIV prevention and treatment protocols, visit the official resources provided by the World Health Organization or your local health ministry.
We welcome your thoughts on this story. Please share this report to help raise awareness about the critical need for sustained global health support.
